Li, Yanping
Sichuan University · West China Hospital of Sichuan University
3 papers on CoChatORCID 0000-0003-1811-0083
Most cited papers
- VerifiedRetracted
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., et al. (2021) · The Lancet
Long-Term Effects of COVID-19COVID-19 Clinical Research Studies
Cited by 4,084
- Verified
Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target
Chen, J., Liu, Q., He, J., & Li, Y. (2022) · Frontiers in Immunology
Chronic Kidney Disease and DiabetesRenal Diseases and Glomerulopathies
Cited by 164
- Verified
The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1
Xi, Y., Li, Y., Xu, P., Li, S., Liu, Z., Tung, H.-C., Cai, X., Wang, J., Huang, H., Wang, M., et al. (2021) · Science Advances
Liver physiology and pathologyRedox biology and oxidative stress
Cited by 67
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free